Branded Drug Report 2023: Lisa Joldersma, PhRMA
In recent decades, pharmacy benefit managers have grown into shadowy and hugely influential players in the prescription drug supply chain. For the most part, they have managed to avoid public scrutiny and government regulation. Fortunately, that’s starting to change, as policy makers find it difficult to overlook rampant conflicts of interest at the core of
